Inaktiver Wert

Andere Sprachen Resaphene Suisse AG

Aktien

Resaphene Suisse AG: FDA Approval Process for Tinnitus Therapy Tinniwell Continues	13.07.22
Resaphene Suisse AG: Tinnitus: 4 phases until healing in the Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell	18.05.20
Resaphene Suisse AG Provides Update on Tinnitus: 4 Phases Until Healing in the Tailor-Made Notched Music Training Discovered with Tinniwell	18.05.20
Resaphene Suisse AG: Correction of the ad hoc announcement dated March 30, 2020 Resaphene Suisse AG has announced the withdrawal of inclusion in the Vienna MTF at the Vienna Stock Exchange	31.03.20
Resaphene Suisse AG: Resaphene Suisse AG has applied for delisting at the Vienna Stock Exchange	30.03.20
Resaphene Suisse AG: Charité Ethics Committee in Berlin Approves Study on Tinniwell Tinnitus Therapy	21.01.20
Resaphene Suisse AG: Charité Ethics Committee in Berlin approves study on tinniwell tinnitus therapy	21.01.20
Resaphene Suisse AG Announces Charité Ethics Committee in Berlin Approves Study on Tinniwell Tinnitus Therapy	21.01.20
Resaphene Suisse AG: Breakthrough in Tinnitus Therapy	13.08.18

Keine Ergebnisse zu dieser Suche